Watch Ticker

BioAge Labs, Inc. Common Stock

Go to BioAge Labs, Inc. Common Stock Website

$4.33

-0.11 (-2.48%)

Live

Previous Close

$4.33

Day Range

$4.307 - $4.49

Previous Day Range

$4.35 - $4.455

Market Cap

$159.2 million USD

Day Vol.

37088

Previous Day Vol.

71296

Currency

USD

Primary Exchange

None

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare c...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - BIOA LEGAL NEWS: A Class Action was filed on behalf of BioAge Labs Investors - Contact BFA Law if You Suffered Losses

A class action lawsuit has been filed against BioAge Labs, Inc. (BIOA) for potential violations of federal securities laws. The lawsuit alleges that BioAge's IPO documents misrepresented the safety profile of its lead drug candidate, azelaprag, leading to the discontinuation of a Phase 2 trial and a significant stock price decline.

Related tickers: BIOA.

Read Full Article

N/A - Deadline Alert: BioAge Labs, Inc. (BIOA) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

BioAge Labs, Inc. (BIOA) is facing a securities fraud lawsuit after its stock price declined 76.85% following the discontinuation of a clinical trial due to liver transaminitis in some subjects. Investors who purchased BIOA stock during the IPO in September 2024 have suffered significant losses.

Related tickers: BIOA.

Read Full Article

Trending Tickers

Please sign in to view